Type 2 diabetes mellitus (T2DM) increases the risk of cardiovascular morbidity and end-stage renal disease. Renin-angiotensin-aldosterone system (RAAS) inhibitors, specifically angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), are standard therapies for organ protection. However, uncertainty remains regarding their comparative efficacy and the safety of combination therapy. This systematic review and meta-analysis aimed to compare the efficacy of ACEIs versus ARBs in reducing cardiovascular and renal events in patients with T2DM and to assess the safety of dual blockade. PubMed, EMBASE, and Cochrane databases were searched for randomized controlled trials (RCTs) published up to 2025 comparing ACEIs, ARBs, or their combination against placebo or active controls in T2DM patients. The primary outcome was a composite of cardiovascular death, myocardial infarction, stroke, and renal failure. Methodological quality was assessed using the Cochrane Risk of Bias 2 tool. Data were synthesized using frequentist pairwise and Bayesian network meta-analyses. Heterogeneity was explored via meta-regression, and trial sequential analysis (TSA) was used to assess the sufficiency of evidence. In total, 16 RCTs involving 47,406 participants were included. In pairwise analysis, both ACEIs (risk ratio (RR) = 0.87, 95% confidence interval (CI) = 0.81-0.94) and ARBs (RR = 0.90, 95% CI = 0.83-0.98) significantly reduced the risk of the primary composite endpoint compared to control. Network meta-analysis showed no statistically significant difference between ACEIs and ARBs (RR = 0.98, 95% CI = 0.88-1.09). Although ACEIs ranked slightly higher in probability for reducing all-cause mortality (surface under the cumulative ranking = 78% vs. 65%), this difference was not statistically significant. Dual blockade (ACEI + ARB) increased the risk of hyperkalemia (RR = 2.8) and acute kidney injury (RR = 1.7) without improving efficacy. Meta-regression identified baseline systolic blood pressure as a significant modifier of treatment benefit (p = 0.04). TSA indicated that the evidence for the RAAS blockade's benefit is conclusive. ACEIs and ARBs exhibit comparable efficacy in preventing cardiovascular and renal events in patients with T2DM, with a marginal mortality benefit favoring ACEIs. Dual blockade is associated with increased harm and is not recommended. Monotherapy with either agent remains the preferred strategy for organ protection.
ACE inhibitorsangiotensin receptor blockerstype 2 diabetesrenin-angiotensin-aldosterone system blockade
Journal of Cardiovascular Development and Disease · مجلد 13 (10) · 478-478
Background: Tricuspid regurgitation (TR) increases mortality but remains undertreated due to high surgical risks. Transcatheter tricuspid valve interventions (TTVI) offer safer alternatives, improving functional status and quality of life. However, many candidates for TTVI have trans-tricuspid CIED leads that may interfere with procedural imaging and device deployment and may be exposed to dislodgement, entrapment, or jailing. Evidence regarding both clinical outcomes and postprocedural CIED function in this population remains limited. Existing trial evidence for this population is scarce, requiring further safety analysis. To our knowledge, this is the first meta-analysis to address the comparative risk of complications and residual TR in patients with vs. without CIEDs. Methods: We searched for relevant articles up to March 2026 from PubMed, Scopus, Cochrane Library, and Web of Science. Two independent reviewers extracted data from the selected studies, including baseline information, outcomes, comorbidities, hospitalization metrics, TR severity, and complications. All data analyses were performed using R version 4.4.1. Results: Ten studies comprising 5415 patients were included. Nine comparative studies contributed to the quantitative synthesis, whereas one single-arm study contributed only to the narrative synthesis of CIED-specific mechanical and electrical outcomes. In patients undergoing TTVI, across two studies, patients with CIEDs had a nominally lower risk of single-leaflet device attachment (RR 0.34, 95% CI 0.12–0.94; nominal p = 0.037); however, this exploratory finding should be considered hypothesis-generating. However, no statistically significant differences were observed between groups for cardiovascular death (RR 1.30, p = 0.815), device embolization (RR 1.62, p = 0.666), device malposition (RR 1.10, p = 0.909), stroke (RR 0.52, p = 0.335), hospitalization for heart failure (RR 1.02, p = 0.931), in-hospital mortality (RR 1.02, p = 0.959), major adverse events (RR 0.74, p = 0.635), major bleeding (RR 0.70, p = 0.187), or residual tricuspid regurgitation of mild (RR 0.98, p = 0.686) or moderate severity (RR 1.01, p = 0.646). CIED-specific outcomes were reported heterogeneously. Lead function was generally preserved after T-TEER in carefully selected patients, whereas studies of TTVR with jailed leads reported lead failure or malfunction ranging from 5.8% to 21% in individual cohorts. Conclusions: Among the comparative outcomes available for quantitative pooling, no statistically significant differences were detected between patients with and without CIEDs for most procedural and postprocedural outcomes. However, CIED-specific risks differed according to the intervention. Lead function was generally preserved after T-TEER in carefully selected patients, whereas lead jailing during TTVR was associated with clinically relevant lead malfunction in some cohorts. Therefore, the absence of significant differences in pooled clinical outcomes should not be interpreted as evidence that TTVI does not affect CIED function.
Post-stroke balance impairment is multifactorial, and limited evidence is available on whether Multimodal Vestibular Training (MVT) provides additional benefits when added to conventional balance training. This study investigated the effect of a four-week MVT program on balance, functional mobility, and quality of life in chronic stroke survivors. After screening 25 stroke patients, 21 eligible chronic stroke survivors were enrolled. Participants were aged 30–75 years, had stroke duration of at least six months, could walk at least 10 m safely under supervision, had MMSE scores ≥ 24, and had Berg Balance Scale scores > 21. Participants were randomly assigned to the experimental group ( n = 11), which received MVT with conventional balance training, or the control group ( n = 10), which received conventional balance training only. Both groups received three supervised 45-minute sessions per week for four weeks. Outcomes were assessed at baseline and post-intervention using the Timed Up and Go (TUG) test, Berg Balance Score (BBS), and Stroke-Specific Quality of Life questionnaire (SS-QoL). Eighteen participants completed the post-intervention assessment and were included in the final analysis, with nine participants in each group. No significant baseline differences were observed between groups. Post-intervention analysis showed significantly better TUG scores in the experimental group than the control group, ( p = 0.002), and significantly better SS-QoL scores ( p = 0.006). Post-intervention BBS scores did not differ significantly between groups ( p = 0.924). Change-score analysis showed significantly greater improvement in the experimental group for TUG ( p = 0.042), BBS ( p = 0.013), and SS-QoL ( p = 0.023). The findings suggest that MVT, when added to conventional rehabilitation, may be associated with improvements in functional mobility and selected quality-of-life outcomes in chronic stroke survivors. BBS scores improved over time, although the post-intervention between-group difference was not significant. Given the limited sample size and short intervention duration, these findings should be interpreted as preliminary and confirmed in larger adequately powered randomized controlled trials. Trial registration: The study protocol was prospectively registered online in the Clinical Trial Registry India (CTRI) at https//www.ctri.nic.in/ with the identifier CTRI/2023/12/060822 dated 18/12/2023.
Background: Stroke-related balance and mobility deficits often persist despite conventional rehabilitation. Virtual reality (VR)-based training may improve functional recovery. This study examined whether short-term VR training enhances clinical mobility outcomes and whether accompanying electroencephalography (EEG) changes reflect global cortical adaptations. Methods: In a prospective single-group repeated-measures study, 28 subacute stroke survivors completed 12 VR sessions over 4 weeks. Outcomes included the Berg Balance Scale (BBS), Timed Up and Go (TUG) test, affected and unaffected limb scores on the Lower-Extremity Motor Coordination Test (LEMOCOT), and resting EEG recorded with the Emotiv EPOC + headset. Assessments were performed at baseline, week 2, and week 4. Global EEG band power was averaged across Fz, Cz, C3, and C4 electrodes. Repeated-measures analyses with adjusted pairwise comparisons and standardized effect sizes evaluated longitudinal changes. Partial correlations controlling for baseline EEG and clinical scores assessed associations between EEG and functional improvement. Results: Clinical outcomes improved significantly over 4 weeks. Mean BBS scores increased from 38.3 to 49.7, TUG time decreased from 68.4 to 47.7 seconds, and affected-side LEMOCOT scores increased from 5.0 to 8.7, with large overall effects. Global EEG power increased progressively in beta, alpha, and theta bands. Balance gains correlated with alpha increases ( r = 0.38 overall; r = 0.63 during weeks 2-4), while mobility improvements and early affected-limb coordination were associated with beta modulation. Conclusions: Four weeks of VR training produced meaningful functional gains alongside widespread increases in cortical oscillatory activity, supporting a mechanistic relationship between VR-induced neuroplasticity and recovery in subacute stroke survivors undergoing rehabilitation.
BACKGROUND: Pulsed field ablation (PFA) is a non-thermal alternative to cryoballoon ablation (CBA) for pulmonary vein isolation in atrial fibrillation (AF). We compared their procedural efficiency, safety, and 1-year outcomes. METHODS: We searched PubMed, Scopus, Web of Science, CENTRAL, and Embase through October 2025 for randomized and comparative cohort studies of adults undergoing PFA or CBA. Outcomes were procedure duration, fluoroscopy time, left-atrial dwell time, periprocedural complications, and 1-year atrial arrhythmia recurrence, synthesized using random-effects meta-analyses with AF-type subgroup analyses. RESULTS: Twenty-three studies were included overall, of which 22 contributed to the quantitative synthesis. Overall, PFA shortened procedure duration versus CBA (mean difference [MD] − 11.50 min, 95% confidence interval [CI] − 15.39 to − 7.62), driven by persistent and mixed AF subgroups, while no significant difference was observed in paroxysmal AF. LA dwell time was reduced with PFA in paroxysmal AF, whereas fluoroscopy time did not differ significantly overall. Stroke, bleeding, and cardiac tamponade were comparable. PFA markedly decreased persistent (risk ratio [RR] 0.31, 95% CI 0.10–0.91) and transient (RR 0.19, 95% CI 0.07–0.53) phrenic nerve palsy. At 1 year, overall pooled analyses showed lower total atrial arrhythmia recurrence (RR 0.79, 95% CI 0.66–0.94) and AF recurrence (RR 0.72, 95% CI 0.62–0.83), with no difference in atrial flutter recurrence. CONCLUSIONS: PFA appears to offer shorter procedures and a more favorable phrenic-nerve safety profile than cryoballoon ablation, without evidence of excess major complications. Apparent 1-year efficacy advantages should be interpreted cautiously because the evidence base is dominated by observational studies and direct randomized PFA-versus-cryoballoon evidence remains limited.
pulsed field ablationcryoballoon ablationpulmonary vein isolationatrial fibrillation
The long-term comparative outcomes of on-pump and off-pump coronary artery bypass grafting (CABG) remain disputed. We performed a random-effects meta-analysis of 25 randomized controlled trials (18,729 patients) comparing on-pump versus off-pump CABG, searching MEDLINE/PubMed, Cochrane CENTRAL, Web of Science, ProQuest, ClinicalTrials.gov, Scopus, and grey literature through 7 June 2025. Outcomes (repeat revascularization, late myocardial infarction, stroke/TIA, late mortality, major adverse cardiovascular events [MACE], and composite endpoints) were pooled as hazard ratios (HR) with 95% confidence intervals (CI), expressed as on-pump versus off-pump. On-pump CABG significantly reduced late myocardial infarction (HR 0.58; p = 0.01). Off-pump CABG was associated with significantly lower MACE (HR 1.62; p = 0.003), with the greatest benefit at 5–10 years (HR 2.18; p < 0.00001) and persisting beyond 10 years (HR 1.89; p = 0.03), and with a lower composite-endpoint risk (HR 1.24; p = 0.04). No significant differences were found for late mortality, repeat revascularization, or stroke/TIA. Risk of bias was moderate to high, and the certainty of evidence was low to very low for most outcomes. On-pump CABG confers a long-term reduction in myocardial infarction, whereas off-pump CABG is associated with a lower MACE and composite cardiovascular event burden; neither technique differs for late mortality, repeat revascularization, or cerebrovascular events. Surgical strategy should be individualized, and further high-quality trials are warranted.
Bioresources and Bioprocessing · مجلد 12 (1) · 21-21
Abstract Enzyme deployment is proliferating extensively in industries owing to their environmentally friendly and easily degradable attributes. This article undertakes an exhaustive examination of wild subtilisin enzyme, covering purification, biochemical delineation, analytical techniques, and practical implementations. The purification methodology involved partial refinement, anionic exchange, and gel filtration chromatography, culminating in a purification factor of 3.406, corroborated by SDS-PAGE showcasing a molecular weight of ~ 42 kDa. Biochemical scrutiny unveiled the enzyme's response, with an optimal pH at 9 and temperature peak at 60 ℃. Various surfactants, metal ions, organic solvents and inhibitors exhibited notable efficacy. Substrate specificity and kinetics showcased the utmost specificity with N-Suc-F-A-A-F- p NA, registering K m and V max values of 0.731 ± 0.5 mM and 0.87 ± 9 × 10 3 U/mg, respectively. Different bioanalytical techniquesproffered insights into structural and biophysical facets. Practical applications encompassed goat skin depilation, feather disintegration, blood clot dissolution, exemplifying the enzyme's multifaceted utility. To embark upon the elucidation of structure–function relationships, a three-dimensional model was devised through homology modelling, leveraging existing subtilisin structures (PDB: 3WHI). Molecular docking score of − 8.8 kcal/mol and dynamic simulations augmented the comprehension of molecular interactions with N-Suc-F-A-A-F- p NA. This research significantly contributes to unravelling the biochemical intricacies of wild subtilisin and underscores potential industrial and biomedical prowess. Subtilisin can be explored for its thrombolytic potential in several cardiovascular diseases. It may aid in the management of thrombosis by dissolving blood clots in conditions like deep pulmonary embolism, myocardial infarction, ischemic strokes, and in atherosclerosis by breaking down fibrin in arterial plaques, thus preventing heart attacks and strokes. Graphical Abstract
Ischemic stroke is globally acknowledged as a prominent reason for disability and mortalities. Oxidative stress, neuroinflammation, and autophagy have been implicated in its pathogenesis. A model of middle cerebral artery occlusion (MCAO) in male rats was conducted for this investigation and the brain cortex was sampled taken after at 1, 6, 12, 24, and 48 h of IRI. The results revealed time-dependent decreases in cortical GSH with rises in MDA and NO levels. Additionally, marked upregulations of inflammatory cytokines were observed and increased as time progressed. Besides, significant upregulations in TLR4, GFAP, Iba-1, and BDNF mRNA expressions were noticed along with increases in the P62 and decreases in LC3 immune expression levels. The pathological findings of cerebral sections showed vacuolations in the neuropil, perivascular edema, and shrinkage of neurons which also increased gradually by time. Taken together, these biomarkers could be reliable indicators for determination of time elapsed after IRI.
Introduction Although diabetes mellitus (DM) is a leading cause of cardiovascular complications, few studies have evaluated the epidemiology of these complications in primary care in Bahrain. Since data from primary care settings are particularly important, as most patients with diabetes are managed in this setting, this study aimed to determine the prevalence and predictors of diabetic complications among patients attending primary healthcare centers in Bahrain. Methods A cross-sectional study was conducted among adult patients with DM attending diabetic clinics in primary care centers across Bahrain. Demographic, clinical, and laboratory data, and diabetes complications were collected. Microvascular (retinopathy, nephropathy, neuropathy) and macrovascular (stroke, acute coronary syndrome, peripheral arterial disease) complications were assessed. Descriptive and inferential analyses were performed. Results A total of 585 patients were enrolled, with a median age of 61±14 years. Most patients were males (n=326, 55.7%), had type 2 DM (n=566, 96.8%), and had uncontrolled diabetes (n=349, 59.7%). Approximately half of the patients (51.6%) had at least one diabetes-related complication. Neuropathy (n=158, 27.0%) and retinopathy (n=89, 15.2%) were the most frequent microvascular complications, while peripheral vascular disease (n=64, 10.9%) and ischemic heart disease (n=61, 10.4%) were the leading macrovascular complications. Multivariable analysis revealed that higher total cholesterol (OR=1.326, p=0.031) and lower estimated glomerular filtration rate, eGFR (OR=1.009, p=0.025) predicted macrovascular complications. Diabetic foot ulcers increased macrovascular complications by 14-fold (p<0.001). Predictors of microvascular complications included type 2 DM (OR=16.277, p=0.011), longer DM duration (OR=1.156, p<0.001), higher triglycerides (OR=1.222, p=0.045), dyslipidemia (p=0.036), and foot ulcers (27-fold; p=0.002). Conclusion Diabetic complications were prevalent among diabetic patients in Bahrain, especially those with impaired renal function, dyslipidemia, anemia, and foot ulcers. Early identification and management of these comorbidities is crucial to prevent diabetes-related complications.
Background: Intracerebral hemorrhage management presents clinicians with a significant therapeutic challenge. Maintaining antiplatelet therapy potentially increases the risk of recurrent bleeding, while discontinuation heightens susceptibility to ischemic stroke, particularly during the critical first month after hemorrhage. In contemporary practice, physicians demonstrate considerable hesitancy regarding early antiplatelet reinitiation, complicated by the absence of clear evidence-based treatment guidelines. Aim: This meta-analysis assesses the safety of early antiplatelet resumption following ICH. Methods: We conducted a systematic review by searching Web of Science, Scopus, PubMed, and Cochrane Library from inception to April 2025. Articles were independently screened and data extracted by two reviewers who also assessed study quality. The inclusion criteria are enrollment of adults (≥18 years) with imaging-confirmed intracerebral hemorrhage surviving >24 h, comparing early vs. delayed or withheld antiplatelet therapy. Randomized trials underwent separate evaluation using Cochrane’s Risk of Bias. Statistical analysis was performed using R software (version 4.4.2), with categorical outcomes pooled as risk ratios (RRs) with 95% confidence intervals. Statistical significance was established at p < 0.05. The evidence is limited by the availability of few RCTs, variable antiplatelet regiments, male predominance, and other confounding factors. The review was registered in SFO. Results: Our meta-analysis included 10 studies (8 observational, 2 RCTs) with 5554 patients. Early antiplatelet therapy significantly reduced recurrent intracerebral hemorrhage by 46% (RR 0.54, 95% CI 0.37–0.78, p = 0.001). All-cause mortality showed a non-significant difference (RR 0.81, 95% CI 0.65–1.01, p = 0.06). No significant differences were found for ischemic stroke (RR 0.99, 95% CI 0.60–1.63, p = 0.96), major hemorrhagic events (RR 0.75, 95% CI 0.49–1.13, p = 0.17), or ischemic vascular outcomes (RR 0.71, 95% CI 0.49–1.02, p = 0.60). Conclusions: Our meta-analysis reveals that early antiplatelet therapy following intracerebral hemorrhage significantly reduces recurrent hemorrhagic events (46% reduction) without increasing major ischemic or hemorrhagic complications.
Saudi Journal of Emergency Medicine · مجلد 6 (3) · 195-200
Background: Neuroimaging plays a critical role in the evaluation of patients presenting with new-onset seizures. This study aimed to explore the epidemiological characteristics of patients presenting to the emergency department (ED) with first-time seizures. Methods: This was a single-center, retrospective cohort study, utilizing data extracted from the electronic hospital system for adult patients who presented with new-onset seizures over a 5-year period. Results: The study included 323 patients (61% male), with a mean age of 43 years. Generalized tonic-clonic seizures were the most common seizure type (84%). Brain computed tomography (CT) scans were normal in 65% of cases, while 35% showed abnormalities, primarily post-stroke sequelae (10.5%), acute stroke (6.8%), and neoplasms (6.5%). Patients with abnormal CT findings were older and had more comorbidities. Logistic regression analysis identified age and focal seizures as significant predictors of abnormal CT findings, while a history of stroke was inversely associated. Conclusion: CT imaging identified abnormalities in 35% of patients with new-onset seizures, with age and focal seizures serving as key predictors. These findings support a risk-based approach to neuroimaging in the ED setting.
new-onset seizuresneuroimagingbrain computed tomographyemergency department
Clinical Medicine And Health Research Journal · مجلد 5 (03) · 1310-1312
Background: Stroke and knee osteoarthritis (OA) are prevalent conditions that significantly impair lower limb function and mobility. While stroke rehabilitation focuses on neuroplastic recovery, the presence of OA may limit neuromuscular gains due to pain, joint stiffness, and disuse. Understanding the neuromuscular adaptations from balance-focused rehabilitation in this dual-diagnosis population is essential. Objective: To evaluate neuromuscular adaptations, particularly in hip stabilizers, and improvements in postural control and gait following an 8-week balance-oriented rehabilitation program in stroke patients with knee OA. Methods: A quasi-experimental study was conducted with 18 post-stroke individuals (mean age 64.3 ± 6.1 years) diagnosed with mild-to-moderate knee OA. Participants completed an 8-week intervention consisting of proprioceptive, static and dynamic balance exercises, and hip/core strengthening. Outcomes included hip muscle strength (Manual Muscle Testing), Functional Reach Test (FRT), Timed Up and Go (TUG), Center of Pressure (COP) metrics (Pedalo®-Sensamove), gait parameters (velocity, stride length, cadence), and EMG activation of the gluteus medius and vastus medialis. Data were analyzed using paired t-tests and Pearson correlation. Results: Significant improvements were observed post-intervention in hip flexor strength (p=0.004), FRT (p=0.008), and anterior COP range (p=0.013). EMG amplitude (RMS) of gluteus medius increased by 24.6% during stance tasks (p=0.002). Improvements in EMG activity were moderately correlated with better TUG and FRT scores. Conclusion: Balance-oriented rehabilitation induces favorable neuromuscular adaptations in stroke patients with OA. Strengthening hip stabilizers and enhancing postural control can mitigate the combined impairments of stroke and OA.
strokeknee osteoarthritisneuromuscular adaptationpostural control
Clinical Medicine And Health Research Journal · مجلد 5 (03) · 1307-1309
Background: Stroke survivors with comorbid knee osteoarthritis (OA) often experience compounded impairments in mobility, balance, and muscle strength. Strength and balance training is an essential rehabilitation strategy to restore function. Objective: This study aimed to examine the effects of an 8-week progressive strength and balance training program on hip strength, dynamic balance, and functional mobility in stroke survivors with knee OA. Methods: A randomized controlled trial was conducted involving 37 post-stroke patients (Group 1: without OA, n=20; Group 2: with OA, n=17). Participants underwent an 8-week intervention comprising hip strengthening, core stability, balance training, and gait exercises. Hip flexor/extensor strength, One Leg Stance (OLS), Functional Reach Test (FRT), Timed Up and Go (TUG), and Center of Pressure (COP) metrics were evaluated pre- and post-intervention. Data were analyzed using repeated measures ANOVA. Results: Significant improvements in hip muscle strength and balance were observed post-intervention in both groups, with a greater percentage change in Group 1. Group 2 exhibited improved but lesser gains. Time × group interaction was significant for OLS, COP range (front and back), and left hip strength (p<0.05). Conclusion: Strength and balance training significantly improved physical function in stroke survivors with and without knee OA. Although OA presence reduced the magnitude of gains, all participants benefitted, suggesting the need for individualized, progressive training programs.
stroke rehabilitationknee osteoarthritisresistance trainingbalance training
International Journal of Physical Therapy Research & Practice · مجلد 4 (5) · 256-263
Background: Stroke patients often experience impaired balance and mobility, which may be exacerbated by comorbid knee osteoarthritis (OA). Hip muscle weakness is a key contributor to reduced dynamic stability in these populations. Objective: To examine the association between hip muscle strength and dynamic balance in stroke survivors with and without knee OA. Methods: This cross-sectional study included 37 post-stroke participants (20 without OA, 17 with OA). Hip flexion and extension strength were assessed using manual muscle testing (MMT). Balance was evaluated via One-Leg Stance (OLS), Center of Pressure (COP) range and sway, and the Functional Reach Test (FRT). Results: Stroke patients with OA demonstrated significantly lower hip strength and impaired balance performance compared to those without OA. Hip flexor and extensor strength on the affected side showed moderate correlations with OLS (r = 0.52), COP sway (r = 0.49), and FRT (r = 0.45). The OA group had reduced OLS time (p < 0.05) and a smaller COP range. Conclusion: Hip muscle weakness is significantly associated with compromised dynamic balance in stroke patients with knee OA, underscoring the importance of hip-focused rehabilitation strategies in this population.
hip muscle strengthdynamic balancestroke survivorsknee osteoarthritis
Journal of Current Health Sciences · مجلد 5 (1) · 15-26
The worldwide occurrence of strokes reaches around 15 million cases per year while these conditions persist in more than 100 million patients at once. Worldwide stroke stands as the second main cause of mortalities since 88% of all stroke deaths occur within low- and middle-income countries (LMICs). Emergency Medical Services establish critical intervention paths because they detect strokes early while providing immediate on-scene treatment and quick response times that directly affect patient recovery. The effectiveness of proposed quality indicators to improve prehospital stroke treatment remains unknown independently from other indicators. The research tackles the developing EMS functions in stroke management through an analysis which shows how prehospital triage tools together with telehealth integration and mobile stroke services shorten the door-to-needle period and improve patient treatment results. The potential of point-of-care diagnostic tools for stroke subtype identification gets investigated to identify their contribution to optimizing prehospital decision-making processes. The text examines crucial issues within prehospital stroke care such as restricted EMS service accessibility and minimal training support and inadequate evidence-based protocol data. The reduction of stroke mortality and improvement of patient recovery requires future research to focus on EMS collaboration with multilevel stakeholders through technology innovation and policy equality to optimize stroke management in underserved healthcare environments.
strokeemergency medical servicesprehospital stroke carestroke management